NanoString Technologies, a company that develops, manufactures and sells diagnostic systems for the analysis of genomic information, filed on Monday with the SEC to raise up to $86 million in an initial public offering. The Seattle, WA-based company, which was founded in 2003 and booked $24 million in sales for the 12 months ended March 31, 2013, plans to list on the NASDAQ under the symbol NSTG. NanoString Technologies initially filed confidentially on November 5, 2012. J.P. Morgan and Morgan Stanley are the joint bookrunners on the deal. No pricing terms were disclosed.
